» Articles » PMID: 8941644

Rapamycin Inhibits Vascular Smooth Muscle Cell Migration

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1996 Nov 15
PMID 8941644
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal vascular smooth muscle cell (SMC) proliferation and migration contribute to the development of restenosis after percutaneous transluminal coronary angioplasty and accelerated arteriopathy after cardiac transplantation. Previously, we reported that the macrolide antibiotic rapamycin, but not the related compound FK506, inhibits both human and rat aortic SMC proliferation in vitro by inhibiting cell cycle-dependent kinases and delaying phosphorylation of retinoblastoma protein (Marx, S.O., T. Jayaraman, L.O. Go, and A.R. Marks. 1995. Circ. Res. 362:801). In the present study the effects of rapamycin on SMC migration were assayed in vitro using a modified Boyden chamber and in vivo using a porcine aortic SMC explant model. Pretreatment with rapamycin (2 ng/ml) for 48 h inhibited PDGF-induced migration (PDGF BB homodimer; 20 ng/ml) in cultured rat and human SMC (n = 10; P < 0.0001), whereas FK506 had no significant effect on migration. Rapamycin administered orally (1 mg/kg per d for 7 d) significantly inhibited porcine aortic SMC migration compared with control (n = 15; P < 0.0001). Thus, in addition to being a potent immunosuppressant and antiproliferative, rapamycin also inhibits SMC migration.

Citing Articles

The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina.

Albadri Z, Almousali R, Abdulla S Glob Cardiol Sci Pract. 2025; 2024(6):e202453.

PMID: 40026588 PMC: 11871560. DOI: 10.21542/gcsp.2024.53.


mTOR signalling controls the formation of smooth muscle cell-derived luminal myofibroblasts during vasculitis.

Stock A, Parsons S, Hansen J, DSilva D, Starkey G, Fayed A EMBO Rep. 2024; 25(10):4570-4593.

PMID: 39271773 PMC: 11467406. DOI: 10.1038/s44319-024-00251-1.


Yohimbine Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation and Migration via FOXO3a Factor.

Lim L, Kim H, Jeong J, Han S, Yu Y, Song H Int J Mol Sci. 2024; 25(13).

PMID: 39000009 PMC: 11240894. DOI: 10.3390/ijms25136899.


Self-expanding intracranial drug-eluting stent system in patients with symptomatic intracranial atherosclerotic stenosis: initial experience and midterm angiographic follow-up.

Zhang F, Yao J, Wu P, Wu Q, Li C, Yang J Neuroradiology. 2024; 66(11):2015-2022.

PMID: 38977434 DOI: 10.1007/s00234-024-03423-x.


Endovascular Drug Delivery.

Lungu C, Creteanu A, Mehedinti M Life (Basel). 2024; 14(4).

PMID: 38672722 PMC: 11051410. DOI: 10.3390/life14040451.


References
1.
Grotendorst G, Seppa H, Kleinman H, Martin G . Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A. 1981; 78(6):3669-72. PMC: 319632. DOI: 10.1073/pnas.78.6.3669. View

2.
Marks A . Cellular functions of immunophilins. Physiol Rev. 1996; 76(3):631-49. DOI: 10.1152/physrev.1996.76.3.631. View

3.
Clowes A, Schwartz S . Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985; 56(1):139-45. DOI: 10.1161/01.res.56.1.139. View

4.
Billingham M . Cardiac transplant atherosclerosis. Transplant Proc. 1987; 19(4 Suppl 5):19-25. View

5.
Standaert R, Galat A, Verdine G, Schreiber S . Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature. 1990; 346(6285):671-4. DOI: 10.1038/346671a0. View